Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-10

Clinical Trial Update: The Effectiveness and Safety for Mesenchymal Stem Cell for Alcoholic Liver Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effectiveness and safety of mesenchymal stem cell therapy for alcoholic liver cirrhosis is being updated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Yonsei University | Conditions: Alcoholic Liver Cirrhosis | Phase 2 | Status: UNKNOWN